| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/05/2004 | CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/05/2004 | CA2493755A1 Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications |
| 02/05/2004 | CA2493701A1 Isothiazole derivatives useful as anticancer agents |
| 02/05/2004 | CA2493156A1 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 02/04/2004 | EP1386922A2 Synthesis of epothilones, intermediates thereof, analogues and uses thereof |
| 02/04/2004 | EP1386915A1 Azole compounds, process for preparation of the same and use thereof |
| 02/04/2004 | EP1386913A1 Pyrrole derivative |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1386317A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | EP1385844A1 Oxazolidinones containing a sulfonimid group as antibiotics |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385838A1 Piperazino-derivatives and their use as pde4 inhibitor |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385833A1 Triazinyl amide derivatives as angiogenesis inhibitors |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385506A2 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 02/04/2004 | EP1385465A2 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473157A 酰胺衍生物 Amide derivatives |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1137122C Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensiv properties, process for their preparation and pharmaceutical compositions containing them |
| 02/04/2004 | CN1137121C Process for preparation of 2-aminothiazolecarboxamide derivatives |
| 02/04/2004 | CN1137118C Water soluble azoles as broad-spectrun antifungals |
| 02/03/2004 | US6686475 Compounds |
| 02/03/2004 | US6686390 Compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them |
| 02/03/2004 | US6686383 Treatment of diabetic nephropathy with a biphenyl-4-yl)alkyl-1h-benzimidazole compounds |
| 02/03/2004 | US6686381 Compounds that antagonize neuropeptide y at the y5 receptor subtype represent an approach to the treatment of eating disorders such as obesity and hyperphagia |
| 02/03/2004 | US6686378 Derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 02/03/2004 | US6686368 Inhibitors of factor Xa |
| 02/03/2004 | US6686363 Effective against multi-resistant bacteria |
| 02/03/2004 | US6686355 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686348 Metalloprotease inhibitors |
| 02/03/2004 | US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents |
| 01/29/2004 | WO2004009573A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | WO2004009565A2 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009551A1 Process for producing 2-substituted pyridine derivative |
| 01/29/2004 | WO2004009543A2 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors |
| 01/29/2004 | WO2004009118A1 Preventive for the onset of diabetes |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | WO2003035613A3 Nitrogen heterocycle inhibitors of aspartyl protease |
| 01/29/2004 | WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/29/2004 | US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor |
| 01/29/2004 | US20040019203 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019089 Multidrug resistant cell inhibitors; anticancer agents |
| 01/29/2004 | US20040019088 Use of Epothilones in the treatment of brain diseases associated with proliferative processes |
| 01/29/2004 | US20040019059 Drugs such as N-(4-benzoylphenyl)-4,5-dihydro-3-(3-pyridinyl)-5-isoxazolecarboxamide, used as antiinflammatory or antiarthritic agents |
| 01/29/2004 | US20040019050 Selective NPY (Y5) antagonists (triazines) |
| 01/29/2004 | US20040019049 Substituted quinazolinone compounds |
| 01/29/2004 | US20040019045 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/29/2004 | US20040019044 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 01/29/2004 | US20040019041 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2004 | US20040019016 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor |
| 01/29/2004 | US20040019015 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 01/29/2004 | US20040018986 Viricide against hepatitis virus |
| 01/29/2004 | US20040018598 Chemical intermediate for discodermolide, epothilone |
| 01/29/2004 | US20040018192 Integrin expression inhibitors |
| 01/29/2004 | CA2493876A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 01/29/2004 | CA2492847A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/28/2004 | EP1384713A1 4-amino-azepan-3-one derivatives as protease inhibitors |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383759A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 01/28/2004 | EP1383757A1 Antagonists of mcp-1 function and methods of use thereof |
| 01/28/2004 | EP1383751A1 Novel azoles having an insecticidal action |
| 01/28/2004 | EP1383749A1 Arylsulfonamides as antiviral agents |
| 01/28/2004 | EP1383744A1 Novel piperidine derivatives as modulators of chemokine receptor |
| 01/28/2004 | EP1383743A2 Dual inhibitors of pde 7 and pde 4 |
| 01/28/2004 | EP1383506A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7 |
| 01/28/2004 | EP1383501A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/28/2004 | EP1383490A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/28/2004 | EP1353908A4 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives |
| 01/28/2004 | EP1299378A4 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/28/2004 | CN1471531A Thiazolidinone nitrate salt |
| 01/28/2004 | CN1471530A A thiazolidinedione derivative and its use as antidiabetic |
| 01/28/2004 | CN1471529A A thiazolidniedione derivative and its use as antidiabetic |
| 01/28/2004 | CN1471522A Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 01/28/2004 | CN1471518A Process for the manufacture of thiazole derivativs with pesticide activity |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1471394A Tripeptidyl peptidase inhibitors |
| 01/28/2004 | CN1136214C Heteroaromatic derivatives |
| 01/28/2004 | CN1136204C Process for preparing 2-imidazoline-5-one fungicide |
| 01/28/2004 | CN1136198C Novel benzyl pyrimidines |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/27/2004 | US6683213 Chemical intermediates for pyridinedicarboxamide herbicides |
| 01/27/2004 | US6683192 Substituted benzo(b)thien compounds useful for modulating proliferation or differentiation of a cell, agonizes hedgehog mediated signal trasnduction with an ed50 of 1mm or less |
| 01/27/2004 | US6683191 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683095 CDK inhibitors having 3-hydroxychromen-4-one structure |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683079 Reverse transcriptase inhibitors |
| 01/27/2004 | US6683077 2-Amino-benzoxazinones for the treatment of viral infections |
| 01/27/2004 | US6683028 Cyclic guanidine derivatives and their use as pesticides |